0.8457
9.36%
-0.0873
시간 외 거래:
.89
0.0443
+5.24%
Karyopharm Therapeutics Inc (KPTI) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
1.84%
33.13
|
33.75 | 36.01 | 37.58 | 38.70 |
Operating Expenses
|
6.53%
66.89
|
71.56 | 67.27 | 67.15 | 69.60 |
Interest Income/Expense |
5.22%
5.884
|
6.208 | 6.073 | 5.784 | 5.758 |
Benefits Costs and Expenses |
6.68%
70.42
|
75.45 | 70.50 | 70.08 | 72.77 |
Costs And Expenses |
6.68%
70.42
|
75.45 | 70.50 | 70.08 | 72.77 |
Operating Income/Loss |
10.71%
-33.76
|
-37.81 | -31.26 | -29.57 | -30.90 |
Nonoperating Income/Loss |
9.41%
-3.532
|
-3.899 | -3.234 | -2.93 | -3.173 |
Income/Loss From Continuing Operations Before Tax |
10.59%
-37.29
|
-41.71 | -34.49 | -32.50 | -34.07 |
Income Tax Expense/Benefit |
45.38%
0.071
|
0.13 | 0.012 | 0.127 | 0.054 |
Income/Loss From Continuing Operations After Tax |
10.70%
-37.36
|
-41.84 | -34.51 | -32.63 | -34.13 |
Net Income/Loss
|
10.70%
-37.36
|
-41.84 | -34.51 | -32.63 | -34.13 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
61,312%
115.45
|
0.188 | 114.40 | 114.21 | 113.48 |
Diluted Average Shares |
61,312%
115.45
|
0.188 | 114.40 | 114.21 | 113.48 |
Basic Earnings Per Share |
11.11%
-0.32
|
-0.36 | -0.30 | -0.29 | -0.30 |
Diluted Earnings Per Share |
11.11%
-0.32
|
-0.36 | -0.30 | -0.29 | -0.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):